Marlín Solórzano

Marlín Solórzano

Auto-generated profile, based on publicly available information

Marlín Solórzano

Department of Endocrinology, Faculty of Medicine Pontificia Universidad Católica de Chile Santiago Chile

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MSMarlín Solórzano
Marlín Solórzano
NLNicole Lustig
Nicole Lustig
LMLorena Mosso
Lorena Mosso
MEMartín Espinoza
Martín Espinoza
RSRoberto Santana
Roberto Santana
JDJosé Miguel Domínguez
José Miguel Domínguez
Objective: After initial treatment, up to 30% of patients with papillary thyroid cancer (PTC) have incomplete response, mainly cervical lymph node (LN) disease. Previous studies have suggested that active surveillance (AS) is a possible option for these patients. Our aim was to report the results of AS in patients with PTC and cervical LN disease. Materials and methods: In this retrospective observational study, we included adult patients treated and followed for PTC, who presented with cervical LN disease and [...] ABSTRACT Objective: After initial treatment, up to 30% of patients with papillary thyroid cancer (PTC) have incomplete response, mainly cervical lymph node (LN) disease. Previous studies have suggested that active surveillance (AS) is a possible option for these patients. Our aim was to report the results of AS in patients with PTC and cervical LN disease. Materials and methods: In this retrospective observational study, we included adult patients treated and followed for PTC, who presented with cervical LN disease and

16 February 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
MSMarlín Solorzano
Marlín Solorzano
Gislaine Granfeldt MolinaGislaine Granfeldt Molina
Gislaine Granfeldt Molina
NUNatalia Ulloa
Natalia Ulloa
Guillermo Molina-RecioGuillermo Molina-Recio
Guillermo Molina-Recio
Rafael Molina-LuqueRafael Molina-Luque
Rafael Molina-Luque
Miquel MartorellMiquel Martorell
Miquel Martorell
The pediatric population has various criteria for measuring metabolic syndrome (MetS). The diversity of consensus for diagnosis has led to different non-comparable reported prevalence. Given the increase in its prevalence in pediatric ages, it is necessary to develop efficient methods to encourage early detection. Consequently, early screening for the risk of MetS could favor timely action in preventing associated comorbidities in adulthood. This study aimed to establish the diagnostic capacity of models that use non-invasive (anthropometric) and invasive (serum biomarkers) variables for the early detection of MetS in Chilean children. A cross-sectional study was carried out on 220 children aged 6 to 11. Multivariate logistic regressions and discriminant analyses were applied to determine the diagnostic capacity of invasive and non-invasive variables. Based on these results, four diagnostic models were created and compared: (i) anthropometric, (ii) hormonal (insulin, leptin, and adiponectin), (iii) Lipid A (high-density cholesterol lipoprotein [HDL-c] and triglycerides [TG]) and (iv) Lipid B (TG/HDL-c). The prevalence of MetS was 26.8%. Lipid biomarkers (HDL-c and TG) and their ratio (TG/HDL-c) presented higher diagnostic capacity, above 80%, followed by body mass index (BMI, 0.71–0.88) and waist-to-height ratio (WHtR, 0.70–0.87). The lipid model A was the most accurate (sensitivity [S] = 62.7%, specificity [E] = 96.9%, validity index 87.7%), followed by the anthropometric model (S = 69.5%, E = 88.8% and validity index = 83.6%). In conclusion, detecting MetS was possible through invasive and non-invasive methods tested in overweight and obese children. The proposed models based on anthropometric variables, or serum biomarkers of the lipid model A, presented acceptable validity indices. Moreover, they were higher than those that measured adipokines, leptin, and adiponectin. The anthropometric model was the most cost-effective and easy to apply in different environments.

22 May 2026 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
NLNicole Lustig
Nicole Lustig
JDJosé Miguel Domínguez
José Miguel Domínguez
SVSergio Vargas‐Salas
Sergio Vargas‐Salas
MHMaría Paz Hernandez
María Paz Hernandez
LMLorena Mosso
Lorena Mosso
HGHernán E. González
Hernán E. González

10 February 2025 in Climacteric
Verified
Journal Article
Closed access
AMAlejandra Martínez-García
Alejandra Martínez-García
JPJorge A. Pérez
Jorge A. Pérez
ATAlejandra Tapia-Castillo
Alejandra Tapia-Castillo
MHMaría P. Hernández
María P. Hernández
MSMarlin Solórzano
Marlin Solórzano
CCCristian Carvajal
Cristian Carvajal
Premenopausal women (PreM) have a cardioprotective advantage over postmenopausal women (PostM) due to estrogen. The interaction of estrogen with the mineralocorticoid receptor (MR) pathway remains unexplored. This study aimed to identify changes in aldosterone, renin and sexual steroid levels and MR surrogate biomarkers in PostM that may explain changes in blood pressure and renal damage. A cross-sectional study was carried out with 47 normotensive and hypertensive Chilean women distributed between PreM and PostM. Clinical, anthropometric and biochemical parameters, including aldosterone, plasma renin activity (PRA) and surrogate markers of MR activity, were assessed. PostM had greater systolic blood pressure (SBP) (p < 0.001) than PreM. A negative correlation was observed between estradiol and fractional excretion of potassium (FEK) (ρ = -0.29; p = 0.023), adjusted for age and SBP. Compared with hypertensive PreM, hypertensive PostM (PostM-HT) showed reduced PRA (p = 0.045) and greater FEK (p = 0.04). Normotensive PostM (Post-NT) exhibited greater SBP (p = 0.03), neutrophil gelatinase-associated lipocalin (NGAL) levels (p = 0.04) and FEK (p = 0.03) than normotensive PreM. Our results suggest enhanced MR sensitivity not only in PostM-HT, as evidenced by lower PRA and elevated FEK, but also in PostM-NT, who exhibited greater FEK and NGAL levels, surrogate markers of MR activation. These results support a novel role of MR activation and cardiovascular risk in PostM women.

4 June 2026 in Medwave
Verified
Journal Article
Closed access
NLNicole Lustig
Nicole Lustig
LRLeticia Rincón
Leticia Rincón
JQJuan Carlos Quintana
Juan Carlos Quintana
VIVirginia Iturrieta
Virginia Iturrieta
IFIgnacio Fuentes
Ignacio Fuentes
JDJosé Miguel Domínguez
José Miguel Domínguez

19 July 2026 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
IFIgnacio Fuentes
Ignacio Fuentes
MSMarlín Solórzano
Marlín Solórzano
AMAnnette Madison
Annette Madison
JFJoel Falcón
Joel Falcón
CRCatalina Ruiz
Catalina Ruiz
JDJosé M. Domínguez
José M. Domínguez